BNP Paribas Financial Markets’s Passage Bio PASG Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q2
$59 Hold
12
﹤0.01% 5822
2026
Q1
$94 Hold
12
﹤0.01% 5688
2025
Q4
$142 Hold
12
﹤0.01% 5589
2025
Q3
$96 Buy
12
+1
+9% +$7 ﹤0.01% 5437
2025
Q2
$90 Buy
11
+2
+22% +$15 ﹤0.01% 5328
2025
Q1
$66 Hold
9
﹤0.01% 5278
2024
Q4
$105 Buy
+9
New +$117 ﹤0.01% 5282

Other funds holding PASG

BNP Paribas Financial Markets's PASG Position: Q2 2026 in Review

BNP Paribas Financial Markets held its Passage Bio (PASG) position steady in Q2 2026 at 12 shares worth $59. The position accounts for ﹤0.01% of the portfolio, ranked #5822.

BNP Paribas Financial Markets first reported a position in PASG in Q4 2024 and has held it in 7 quarters since. The position peaked at $142 in Q4 2025. 19 funds tracked by Wall St. Rank hold PASG as of Q2 2026.

  • BNP Paribas Financial Markets held 12 shares of Passage Bio worth $59 as of Q2 2026.
  • BNP Paribas Financial Markets left its Passage Bio share count unchanged in Q2 2026.
  • Passage Bio made up ﹤0.01% of BNP Paribas Financial Markets's portfolio in Q2 2026, its #5822 holding.
  • BNP Paribas Financial Markets first reported a position in Passage Bio in Q4 2024 and has held it in 7 quarters since.
  • BNP Paribas Financial Markets's Passage Bio position peaked at $142 in Q4 2025.
  • 19 funds tracked by Wall St. Rank held Passage Bio as of Q2 2026.

Based on BNP Paribas Financial Markets's 13F filing for Q2 2026, filed 13 Aug 2026.